NCT07035821View on ClinicalTrials.gov

Olanzapine for Prevention of Vomiting in Children and Adolescents Receiving Highly Emetogenic Chemotherapy

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

July 1, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

July 30, 2026

Conditions
Breakthrough Chemotherapy-Induced Vomiting (CIV) in Pediatric PatientsPediatric Cancer
Interventions
DRUG

Olanzapine Tablets

Oral olanzapine tablets

DRUG

Placebo

Oral placebo

Trial Locations (1)

Unknown

Shanghai Children's Medical Center, Shanghai

All Listed Sponsors
lead

Shanghai Children's Medical Center

OTHER